JPMorgan lowered the firm’s price target on Alexandria Real Estate (ARE) to $95 from $117 and keeps an Overweight rating on the shares. The firm says that while life science fundamentals remain challenged, the likelihood of Alexandria continuing to capitalize interest against its long-term projects goes down, and investment gains in its venture capital book “could dwindle.” The firm says taking a more cautious approach to both of these items has a material impact on the company’s funds from operations. However, JPMorgan sees intrinsic value in the stock at current levels despite its reduced estimates.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARE:
